Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.38 USD | 0.00% | +4.94% | -1.60% |
Apr. 05 | RTW Biotech invests in cell and gene therapy company Obsidian | AN |
Mar. 28 | RTW Biotech Opportunities Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Sales per Business
USD in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100.0
%
| 15 | 100.0 % | 6 | 100.0 % | -61.68% |
Sales per region
USD in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
Guernsey
100.0
%
| 15 | 100.0 % | 6 | 100.0 % | -61.68% |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Simpson
CHM | Chairman | 68 | - |
Paul Le Page
BRD | Director/Board Member | - | 19-10-29 |
William Scott
BRD | Director/Board Member | 64 | 19-10-29 |
Stephanie Sirota
BRD | Director/Board Member | 49 | 19-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 384,686,512 | 337,541,702 ( 87.74 %) | 0 | 87.74 % |
Company contact information
RTW Biotech Opportunities Ltd.
,
+646 597 6980
1st Jan change | Capi. | |
---|---|---|
-1.60% | 531M | |
+6.09% | 12.85B | |
+12.28% | 9.57B | |
+0.80% | 5.6B | |
+4.67% | 5.5B | |
+6.13% | 5.21B | |
+19.43% | 4.64B | |
+18.68% | 4.48B | |
+2.49% | 4.07B | |
+3.73% | 3.92B |
- Stock Market
- Equities
- RTWG Stock
- Company RTW Biotech Opportunities Ltd